Clay Thorp
CIK 1592380 · last filed 2025-02-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
49
Lifetime Open-Market Net
$23.32M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Clearside Biomedical, Inc. (CLSD) Delisted | Director | 3,721,181 | $0.35 | $1.31M | $17.97M | 33 | 2025-02-24 |
| PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Director | 48,375 | $0.07 | $3.4K | $1.51M | 12 | 2022-05-20 |
| Vigil Neuroscience, Inc. (VIGL) Delisted | Director | 1,544,137 | $8.05 | $12.43M | $3.84M | 3 | 2022-05-17 |
Recent Filings · Page 5 of 5
49 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-05-19 | Clearside Biomedical, Inc. (CLSD) Delisted | Sell (S) | −24,000 | -$200.6K | EDGAR |
| 2017-05-17 | Clearside Biomedical, Inc. (CLSD) Delisted | Sell (S) | −44,485 | -$384.1K | EDGAR |
| 2017-04-19 | Clearside Biomedical, Inc. (CLSD) Delisted | Sell (S) | −68,485 | -$510.9K | EDGAR |
| 2017-03-17 | Clearside Biomedical, Inc. (CLSD) Delisted | Sell (S) | −68,485 | -$449.5K | EDGAR |
| 2017-02-22 | Clearside Biomedical, Inc. (CLSD) Delisted | Sell (S) | −27,000 | -$203.7K | EDGAR |
| 2017-02-17 | Clearside Biomedical, Inc. (CLSD) Delisted | Sell (S) | −41,485 | -$315.1K | EDGAR |
| 2017-01-20 | Clearside Biomedical, Inc. (CLSD) Delisted | Sell (S) | −68,485 | -$584.0K | EDGAR |
| 2016-06-07 | Clearside Biomedical, Inc. (CLSD) Delisted | Mixed | +14,239,015 | $20.30M | EDGAR |
| 2016-06-07 | Clearside Biomedical, Inc. (CLSD) Delisted | Mixed | +4,150,771 | $5.50M | EDGAR |
Showing 41–49 of 49
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.